DoctorJac Charlesworth

Adjunct Senior Researcher

Menzies Institute for Medical Research

  • Adjunct Senior Researcher
    Menzies Institute for Medical Research
  • +61 3 6226 4607 (Work)
  • University of Tasmania, IT Services, Corporate Services Building, TT Flynn St, Sandy Bay, TAS, 7005, Australia

BIO

Complex diseases that involve multiple genes interacting with the environment have traditionally been very difficult to study compared to diseases that are caused by a variation in a single gene. However, recent advances that allow the rapid sequencing of the vast amount of DNA that makes up a person’s genome, together with the computing power to analyse and make sense of this data, are helping scientists begin to untangle these complex diseases.

Searching for critical clues in our DNA

In her work at the Menzies Institute for Medical Research, Dr Jac Charlesworth uses these tools – known as computational genomics – to study complex neurological diseases, in particular multiple sclerosis (MS). MS is a devastating neurological condition that affects young adults in which a person’s own immune system attacks their brain and spinal cord.

Dr Charlesworth carries out genome sequencing studies to identify genetic variations that contribute to the risk of developing MS. She believes families hold the key to understanding why some people are susceptible to immune system attack and why some people are not. By sequencing the genomes of people in families where there are an unusual number of MS cases, she looks for differences in the genetic profiles of people with and without the disease.

‘Families already have very similar genomes, so it makes it easier to find the big differences that relate to MS,’ she says.

Tasmania, with its isolation and relatively stable population, is an ideal place for Dr Charlesworth’s research. ‘The people of Tasmania are amazing; they’re prepared to be involved in these studies and they are enthusiastic about participating.’

Some 200 genetic variations are already known to contribute to the risk of developing MS but, together, they still account for less than 50 per cent of the total genetic risk. ‘Many of these genetic variations have only a very small influence on the overall risk,’ Dr Charlesworth says. ‘I am interested in identifying those genes that are relatively large contributors to disease risk at the level of the individual person.’

When Dr Charlesworth finds a genetic variation that seems to be important, she works with colleagues at the Menzies Institute to grow stem cells from people with the mutation. These stem cells can then be turned into different nerve cells and the differences between cells with the mutation and those without can be studied. In particular, she looks for genetic variations that affect the proper development and maintenance of the nervous system in people with MS, for example, the laying down of the myelin sheath around nerve cells.

Working with these cells, Dr Charlesworth and her colleagues can also study the effectiveness of drugs against MS. There is no cure for MS and currently the only real option is to switch off parts of the immune system. ‘We are interested in finding drug targets that can aid in neural protection and repair. The hope is to find drugs that can be used to protect people who are at risk and that are also effective in treating people who already have the disease.’

Dr Charlesworth runs a computational genomics research group at the Menzies Institute for Medical Research at UTAS. She has a particular interest in complex disease gene discovery using next-gen sequencing in large families, and of using 'normal' population variation to inform disease research. She is a statistical geneticist with a background in molecular biology, allowing her to occupy the interface between data analysis and biological interpretation.

Dr Charlesworth is currently hunting for genetic variation underpinning neurological disorders including multiple sclerosis, eye diseases including glaucoma, and other complex traits including cancers, diabetes and brain structural variation. She also manages the computational infrastructure for genomics research at Menzies, and provides bioinformatics training and support.

Biography

Dr Charlesworth obtained her PhD in statistical genetics from the University of Tasmania in 2006. She then spent four years as a postdoctoral fellow at the Texas Biomedical Research Institute (formerly Southwest Foundation for Biomedical Research) in the USA. In 2010 she returned to Australia where she is now a Senior Research Fellow in computational genomics at the Menzies Institute for Medical Research; providing analytical support to a wide range of studies at the institute while maintaining her own research into complex disease.

SCHOOL AND PORTFOLIO

  • Menzies Institute for Medical Research

FIELD OF RESEARCH